ANASTACIA LEATHERWOOD: Open Payments
NPI 1164948188 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 57 payments from 22 companies in 2025. Trend: 2023 $1,592 · 2024 $1,233 · 2025 $1,353
Food & beverage: $1,353
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $147 |
| Dexcom, Inc. | 1 | $143 |
| Amgen Inc. | 10 | $138 |
| Lilly USA, LLC | 7 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $118 |
| Sumitomo Pharma America, Inc. | 4 | $106 |
| Enterra Medical, Inc. | 1 | $101 |
| Radius Health, Inc. | 4 | $73 |
| ABBVIE INC. | 3 | $71 |
| Axsome Therapeutics, Inc. | 2 | $49 |
Products named: Dexcom G6 Transmitter, GATTEX, Wegovy, GEMTESA, OTEZLA, JARDIANCE, Tymlos, VRAYLAR.
Industry payments across TX — which companies pay providers there.
